All posts by imreal

Local Manhattan Beach Dental Office Joins the Boys and Girls Clubs in the War Against Illiteracy!


Dr. Mungcal provides care with the goal of helping his patients keep their natural teeth for as long as possible, hopefully for life! This does not merely mean that natural teeth are present, but that they look good, feel good, and function well because of excellent care.

Dr. Mungcal, having served his community for many years, was quoted as saying, “This is an outrage! Only someone who doesn’t care about this city and our children would keep this quiet. Something should be done about this!”

During a special leadership event held in Florida, several business owners joined forces and decided to band together to do something about this.

They started by sending over 1,000 books to Boys and Girls Clubs in their communities. The mission of Boys and Girls Clubs is to enable all young people to reach their full potential as productive, caring, responsible citizens, especially those in need. These leaders support the vision of this national network of world-class clubs putting hope and safety within reach of every young person and putting them on track to graduate from high school with a plan for the future, learning good character and citizenship, and living a healthy lifestyle.

Reading is a cornerstone skill for our youth!

Dr. Mungcal said, “We want to do our part. And we want everyone in this city to know about this program and support it. Boys and Girls Clubs are leading the way in showing us that something can be done about it; something can be done about illiteracy by everyone pitching in.” and further stated “I believe that children and young adults who are shown what’s possible through literature can achieve their dreams. What’s more, receiving the gift of reading really makes them happy and ignites their imagination. I love making giving them this opportunity.”

About the Doctor

Dr. Don Mungcal:

Dr. Don Mungcal is a native of the Los Angeles area and loves serving his neighbor’s dental needs. Raised in the San Fernando Valley, he completed undergrad studies at UCLA. He received his degree with honors in 1990 after completing the dental program at University of the Pacific Dental School in San Francisco. His post-graduate experience came in part from his role as an instructor at USC Dental School. Within a few short years, Dr. Mungcal established his practice right in his hometown of Los Angeles. Manhattan Beach Dental has been serving patients since 1992.

He has been honored as a Best Dentist in Downtown in “Los Angeles Downtown News” for four consecutive years.

Dr. Mungcal stays abreast of cutting-edge dental technologies and techniques through activity in the California Dental Society. He is also a member of several other prestigious dental organizations. He stays up to date with the latest dental implants, general dentistry, and cosmetic dentistry advancements by investing hundreds of hours in continuing education courses each year.

Dr. Mungcal provides care with the goal of helping his patients keep their natural teeth for as long as possible, hopefully for life! This does not merely mean that natural teeth are present, but that they look good, feel good, and function well because of excellent care.

Dr. Don Mungcal

Beachside Smiles

Family & Cosmetic Dentistry

1590 Rosecrans Ave Ste. N

Manhattan Beach, CA 90266

310-643-6004

info@beachsidesmiles.com

Share article on social media or email:

Luminex to Host their 2023 Virtual xMAP Connect Conference, January 31, 2023


Luminex to Host their 2023 Virtual xMAP Connect Conference, January 31, 2023

Luminex to host their Virtual xMAP Connect Conference on January 31st, 2023 on the Labroots platform.

At Luminex’s Virtual Conference, expect to learn about their xMAP Technology, and how it enables to evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. Luminex’s xMAP Technology offers the versatility to perform a wide range or protein or nucleic acid based multiplex assays on a single platform.

During this virtual program, you can expect to hear from multiplex experts about how they’ve developed, validated, and optimized their methods, as well as learn about innovative research and clinical applications of xMAP Technology.

Join the xMAP Connect Virtual Event to

  • View webinars and posters—by scientists, for scientists—to gain insights from industry experts
  • Access a wide selection of resources, such as white papers, application notes, technical handbooks, product demo videos, and product selection guides
  • Join Luminex’s live Q&A session to connect with application scientists and speakers from the webinars to get multiplexing tips and tricks, plus troubleshooting help
  • Visit Luminex Partner booths to learn more about xMAP-based multiplexing solutions

To register for the event, and view the agenda, click here.

About Luminex

At Luminex, we envision a solution in every lab around the world seeking to obtain timely and confident answers. We aim to lead with transformative solutions that uniquely accelerate reliable answers while reducing the overall cost of advancing health. Luminex offers a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, and food safety. They accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. For more information, visit Luminexcorp.com.

About Labroots

Labroots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars and more. Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks and communities. Founded in 2008, Labroots emphasizes digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, Labroots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events. Now, Labroots offers more than ever with Chati, a flexibile highly scalable event platform that allows for the creation of unique, effective, and memorable virtual events.

Share article on social media or email:

Life Molecular Imaging Announces Start of the Phase 3 Histopathology Study “ADvance” for the Tau PET Tracer [18F]PI-2620


ADvance - [18F]PI-2620 Phase 3 histopathology study

ADvance – [18F]PI-2620 Phase 3 histopathology study

We are proud to announce the start of this Phase 3 study, which marks another milestone on our vision to reduce the burden of disease by improving early diagnosis and characterization of chronic and life-threatening diseases.

Life Molecular Imaging (LMI) announces today that the first patient has been imaged with [18F]PI-2620 in the ADvance Phase 3 clinical study. This study is an open-label, multi-center, non-randomized pivotal Phase 3 study to assess the efficacy and safety of PET imaging with [18F]PI-2620 for detection of tau deposition in subjects with Alzheimer’s disease (AD) during lifetime when compared to histopathology obtained after death and completion of brain autopsy.

The ADvance study will be performed exclusively in the US and will enroll approximately 200 end-of-life subjects. The primary objective is to determine the sensitivity and specificity of the visual assessment of [18F]PI-2620 PET imaging compared to postmortem histopathological verification of tau neurofibrillary pathology associated with AD as the standard of truth.

[18F]PI-2620 is a potentially best-in-class tau PET tracer with high binding affinity and selectivity for aggregated tau. Tau aggregates are an important indicator of neuronal death and correlate strongly with cognitive decline in AD. Accurate detection of aggregated tau may therefore contribute to improved diagnosis and advanced monitoring of cognitive performance in patients with dementia.

“A validated tau PET tracer will lead to an improved understanding of the pathophysiology of tauopathies and may aid in establishing an earlier and more accurate clinical diagnosis of neurodegenerative diseases”, said Dr. Ludger Dinkelborg, CEO of Life Molecular Imaging. “We are proud to announce the start of this Phase 3 study, which marks another milestone on our vision to reduce the burden of disease by improving early diagnosis and characterization of chronic and life-threatening diseases. This unique tau imaging biomarker is an important addition to Neuraceq®, our approved and globally available beta-amyloid targeting product, thereby complementing our neurodegeneration portfolio”.

Dr. Andrew Stephens, M.D., Ph.D., Chief Medical Officer at Life Molecular Imaging added: “We are highly encouraged by the clinical data obtained to date with our tau PET tracer [18F]PI-2620. We are very much looking forward to continuing the development of [18F]PI-2620 as the potentially best-in-class tau PET tracer in patients with AD by starting this Phase 3 study.”

The availability of a reliable and validated diagnostic agent to visualize disease development in patients with AD is critical for the successful development of novel therapies targeting amyloid and tau deposition. [18F]PI-2620 has the potential to become a diagnostic agent that can identify tau in AD and other tauopathies at an early stage and will help to advance the understanding of the pathophysiology of neurodegenerative diseases.

Further details of the ADvance Phase 3 study design are available on clinicaltrials.gov (NCT05641688).

About [18F]PI-2620

[18F]PI-2620 was discovered and developed as part of a research collaboration between AC Immune and LMI. LMI has the exclusive, worldwide license for research, development and commercialization of tau PET tracers generated within the discovery program. It has demonstrated robust brain uptake and fast wash-out in non-target regions, a broad imaging window between 30 and 90 minutes post-injection for AD, and excellent reproducibility between test and retest scans. The absence of significant off-target binding enables [18F]PI-2620 to detect and quantify early tau deposition in the brain.

[18F]PI-2620 is currently under investigation in several clinical studies as a targeted radiopharmaceutical for the detection of tau deposits in the human brain. [18F]PI-2620 also shows promise for non-AD tauopathies like progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS).

About Neuraceq® (florbetaben 18F)

Indication

Neuraceq® is a radioactive diagnostic agent indicated for Positron Emission Tomography (PET) imaging of the brain to estimate beta amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD) and other causes of cognitive decline.

A negative Neuraceq® scan indicates sparse to no amyloid neuritic plaques and is inconsistent with a neuropathological diagnosis of AD at the time of image acquisition; a negative scan result reduces the likelihood that a patient’s cognitive impairment is due to AD. A positive Neuraceq® scan indicates moderate to frequent amyloid neuritic plaques; neuropathological examination has shown this amount of amyloid neuritic plaque is present in patients with AD but may also be present in patients with other types of neurologic conditions as well as older people with normal cognition. Neuraceq® is an adjunct to other diagnostic evaluations.

Limitations of Use

A positive Neuraceq® scan does not establish the diagnosis of AD or any other cognitive disorder.

Safety and effectiveness of Neuraceq® have not been established for (i) predicting development of dementia or other neurologic conditions and (ii) monitoring responses to therapies.

Important Safety Information

Risk for Image Interpretation and Other Errors

Neuraceq® can be used to estimate the density of beta-amyloid neuritic plaque deposition in the brain. Neuraceq® is an adjunct to other diagnostic evaluations. Neuraceq® images should be interpreted independent of a patient’s clinical information. Physicians should receive training prior to interpretation of Neuraceq® images. Following training, image reading errors (especially false positives) may still occur. Additional interpretation errors may occur due to, but not limited to, motion artifacts or extensive brain atrophy.

Radiation Risk

Administration of Neuraceq®, like other radiopharmaceuticals, contributes to a patient´s overall long-term cumulative radiation exposure. Long-term cumulative radiation exposure is associated with an increased risk of cancer. It is important to ensure safe handling to protect patients and health care workers from unintentional radiation exposure.

Most Common Adverse Reactions

In clinical trials, the most frequently observed adverse drug reactions in 872 subjects with 1090 Neuraceq® administrations were injection/application site erythema (1.7%), injection site irritation (1.1%), and injection site pain (3.4%).

For full prescribing information visit https://neuraceq.com/wp-content/uploads/2022/09/PRESCRIBING-INFORMATION.pdf

About Life Molecular Imaging (LMI)

Life Molecular Imaging (LMI, formerly Piramal Imaging) was formed in 2012 with the acquisition of the molecular imaging research and development portfolio of Bayer Pharma AG. It is now part of the Alliance Medical Group (a member of the Life Healthcare Group) offering an integrated business including research and development laboratories, a network of cyclotrons, radiopharmacies and imaging facilities. By developing novel PET tracers for molecular imaging, LMI is focusing on a key field of modern medicine. The organization strives to be a leader in the Molecular Imaging field by developing innovative products that improve early detection and characterization of chronic and life-threatening diseases, leading to better therapeutic outcomes and improved quality of life. Please visit https://life-mi.com.

About Life Healthcare Group

Life Healthcare is a global people-centered, diversified healthcare organization listed on the Johannesburg Stock Exchange. Life Healthcare has over 38 years’ experience in the South African private healthcare sector, and currently operates 66 healthcare facilities in southern Africa. Services include acute hospital care, acute physical rehabilitation, acute mental healthcare, renal dialysis, and wellness, occupational health, primary health and emergency medical services. The Group owns Alliance Medical Group, the leading independent provider of medical imaging services (MRI, CT and PET scans) within Europe, operating internationally across 10 countries. Life Molecular Imaging, a division of Alliance is an integrated pharmaceutical business that includes research and development laboratories, access to a network of cyclotrons and radio-pharmacies and imaging facilities, with Life Radiopharma being Alliance’s distributor of radiopharmaceuticals to diagnose many types of diseases. Visit https://www.lifehealthcare.co.za/

For media inquiries

Contact:

Andre Mueller, Clinical & Preclinical R&D, Life Molecular Imaging, ADvance@life-mi.com

Share article on social media or email:

State Donates $13,000 to Fight Food Insecurity and Homelessness


“Our team strives to make a difference in the lives of our clients and their patients every day. This is another example of our team’s compassionate spirit and desire to help others in our communities,” Tim Haag, State president.

In the spirit of the season, the State team continued its annual holiday tradition of donating $13,000 to assist families in our communities.

The generosity of State’s team was donated to organizations combatting food insecurity and homelessness. Donations were made to local agencies in the communities where State has a physical office and to Feeding America on behalf of our remote staff members. Donations were made to:

House of Mercy – Beloit, Wis.

DAIS – Madison, Wis.

Hope House – Milwaukee, Wis.

St. Peter’s Catholic Church Food Pantry – Geneva, Ill.

Feeding America – Remote Staff

State President Tim Haag, and his wife Kristen, made a $1,000 personal pledge if the team reached the fundraiser goal. The team came together to beat the goal! When combined with the company match, the gift continued the 2022 trend of record-breaking donations.

Earlier in the year, State donated to Special Olympics as well as a donation in honor of Tom Haag to Cars Curing Kids. State, and the Haag family, appreciate the generosity of our partners and industry friends who joined with us to honor Tom and his legacy.

“I am extremely proud of the generosity of our team. When combined with company contributions, I am grateful we are able to help families in need by donating nearly $90,000 in 2022,” said Tim Haag. “Our team strives to make a difference in the lives of our clients and their patients every day. This is another example of our team’s compassionate spirit and desire to help others in our communities.”

About State

State improves the financial picture for healthcare providers by delivering increased financial results while ensuring a positive patient experience. Rooted in a tradition of ethics, integrity and innovation since 1949, State uses data analytics to drive performance and speech analytics with ongoing training to ensure patient satisfaction. A family-owned company now in its third generation of leadership, State assists healthcare organizations with services spanning the complete revenue cycle including Pre-Service Financial Clearance, Early Out Self-Pay Resolution, Insurance Follow-Up and Bad Debt Collection. To learn more visit: http://www.statecollectionservice.com.

Share article on social media or email:

AZZLY® Rize™ Electronic Health Record Earns ONC Certification


News Image

“We are committed to achieve and support the rigorous compliance objectives of the ONC,” said Coletta Dorado, Founder and CEO of AZZLY. “Over the years, the ONC has made the appropriate changes to recognize the unique real life use cases of behavioral healthcare so certification makes sense.”

AZZLY, Inc., a leading behavioral and addiction treatment digital health solution, announced today that it has received ONC-ACB EHR 2015 Cures Update certification through the Drummond Group.

ONC Certification (short for Office of the National Coordinator (ONC) for Health Information Technology Certification) ensures that Certified Health Information Technology meets the technological capability, functionality, and security requirements adopted by the United States Department of Health and Human Services (HHS).

AZZLY’s solution, called AZZLY Rize™, is the premier clinical and business platform for residential and outpatient addiction treatment and mental healthcare organizations. As an all-in-one addiction treatment and mental healthcare-specific electronic health record (EHR) and revenue cycle management (RCM) system, AZZLY serves the clinical and business needs of small, medium, and large organizations across all Levels of Care (LOC) and Programs offered.

AZZLY earned certification from the Office of the National Coordinator to further their goal of providing a cutting-edge modern platform to healthcare professionals. ONC evaluates systems for security, reliability, and accessibility.

AZZLY Rize is purpose-built to scale with mental health treatment centers to support growth and increase efficiency. AZZLY designed their solution to include e-check-in, scheduling, appointment reminder, EHR, telehealth, treatment plans, progress notes, outcome measurement tools, medication management, bed board, withdrawal management, e-prescribing, EPCS, PDMP, patient communication tools and electronic billing and claims submission.

“We are committed to achieve and support the rigorous compliance objectives of the ONC” said Coletta Dorado, Founder and CEO of AZZLY. “Over the years, the ONC has made the appropriate changes to recognize the unique real life use cases of behavioral healthcare so certification makes sense.”

AZZLY manages its infrastructure and platform services on Microsoft Azure private cloud network, recognized as a Leader in the 2022 Gartner Magic Quadrant for Cloud Infrastructure and Platform Services. AZZLY proudly serves healthcare providers throughout the USA.

A full report of AZZLY’s ONC certification is available at https://chpl.healthit.gov/#/listing/11073 under CHPL Product Number: 5.04.04.1029.Rize.01.00.0.221214 and ONC-ACB Certification ID: 15.04.04.1029.Rize.01.00.0.221214.

About AZZLY, Inc.:

Coletta Dorado founded AZZLY®, Inc. in 2009. Since 2014, AZZLY leadership has focused all resources on its behavioral healthcare platform, AZZLY Rize™, to meet the specific clinical and business needs of addiction treatment and mental healthcare organizations. AZZLY was recognized as a key player in the Global Patient Care Management Software industry (2020), on the Capterra® Shortlist™ for Mental Health Software (2021), a Software Advice® Frontrunner™ for Mental Health Software (2021), and an honorable mention for the Healthiverse Heroes Awards™ by DrFirst® (2022). Email hello@azzly.com or visit azzly.com for more information.

Share article on social media or email:

Creating Digital Biomarkers with Real-World and Existing Data, Upcoming Webinar Hosted by Xtalks


Often thousands of people must be monitored over an extended period to validate a single digital biomarker for a single condition.

Digital health technologies have the potential to revolutionize medicine, shifting the focus from reactive treatment to proactive prevention of acute illness. Although many of these technologies have existed for up to 30 years, adoption has been slow. The primary reason is there are few accepted digital biomarkers that indicate whether a person is getting better or worse — let alone identify when an intervention is recommended.

Validating a digital biomarker can be a huge task. The biomarker must be shown to reliably measure every application in every population where it will be employed. Often thousands of people must be monitored over an extended period to validate a single digital biomarker for a single condition. But that is not the only challenge. Currently, most of the scientific work on this issue is conducted in highly tailored studies tying a specific biomarker to a specific condition in a specific population and often to the action of a specific therapeutic. As a result, the Digital Medicine Society’s Library of Digital Endpoints (aka biomarkers) now has more than 70 distinct measures of activity and 55 measures of sleep. Healthcare providers cannot be expected to apply dozens of different measures of essentially the same phenomenon. These need to be standardized. All together, these challenges may seem insuperable.

The featured speakers believe these challenges can be overcome by leveraging real-world data and reusing existing data, so the benefits of digital medicine can finally be reaped. This webinar will cover: What to look for in digital biomarkers; What it takes to validate a digital biomarker; Why real-world data are critical to this effort; A case study showing how to reuse existing data to validate an open-source digital biomarker; Key success factors to enable reuse of data; Regulatory and clinical decision-making factors; And patient privacy issues.

Attendees looking to develop and/or validate digital biomarkers will find this webinar very informative. Register today to learn more about creating digital biomarkers with real-world and existing data.

Join Dr. Daniel R. Karlin, MD, MA, Chief Medical Officer, MindMed; Dr. James Connolly, Lecturer in Computing at Atlantic Technical University, Co. Donegal, Ireland; Dr. William Crown, Distinguished Scientist at Brandeis, The Heller School for Social Policy and Management; and Geoff Gill (webinar moderator), President, Shimmer Research Inc., for the live webinar on Thursday, February 2, 2023, at 1pm EST (10am PST).

For more information, or to register for this event, visit Creating Digital Biomarkers with Real-World and Existing Data.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Kids & Teens Dental Place Announces Launch Of New Website


Kids & Teens Dental Place

Kids & Teens Dental Place

We are committed to providing patients and their families with the highest level of care in a fun, comfortable environment. We want every child to love coming to the dentist.

Kids & Teens Dental Place is excited to announce the launch of its newly redesigned website, located at a new domain, KidsAndTeensDentalPlace.com. The website features new content and a fresh look that will help the growing practice meet the needs of the communities in Pearland and Houston, Texas. The website includes information about the latest pediatric dentistry and procedures, insight into our state-of-the-art clinics, articles about pediatric dental health, and more.

The practice’s new website is designed to help parents learn more about general pediatric dentistry procedures. Parents can learn about common childhood dental problems and treatments for children and teens, as well as discover information about teeth-cleaning and fluoride treatments for kids. The website also features a section about aftercare for the different types of pediatric dental procedures performed by the staff at Kids & Teens Dental Place.

Kids & Teens Dental Place is led by pediatric dentist Dr. Cecilia Carpio and prosthodontist Dr. Alvaro Carpio. They are joined by a team of dedicated and compassionate pediatric dental assistants, hygienists, and receptionists who aim to make each patient’s experience as smooth and stress-free as possible. Both of the practice’s offices in Pearland and Houston are designed with kids in mind and have plenty of parking as well as a spacious waiting room for families. The offices have fun and colorful decor that appeal to children and make them feel comfortable during their visits.

“We are committed to providing patients and their families with the highest level of care in a fun, comfortable environment,” says Dr. Cecilia Carpio. “We want every child to love coming to the dentist.”

Dr. Cecilia Carpio is a board-certified pediatric dentist who received her Doctorate in Dental Surgery and then continued her studies at Cayetano Heredia University, where she also served as a faculty member. From there, she received her Pediatric Dental Certificate from the University of Alabama Birmingham following a residency at the Children’s Hospital of Alabama. She is fluent in English, Spanish, and American Sign Language. She is a member of the American Academy of Pediatric Dentistry, the International Association of Pediatric Dentistry, the American Dental Association, and the Texas Dental Association, amongst other professional associations.

Dr. Alvaro Carpio is a second-generation dentist who has been practicing for over 15 years. Following some time in private practice, he continued his education at the University of Puerto Rico, where he received his advanced graduate studies certificate in prosthodontics. Dr. Carpio is also certified in Basic Life Support and Pediatric Advanced Life Support, as well as in administering sedation.

The practice offers a range of pediatric dentistry services, including treatment for dental emergencies, comprehensive oral checkups and preventative care, fillings, sealants, and fluoride treatment for children. The dentists also diagnose and treat toothaches, gum disease, and any other oral health issues that may arise in children. They are happy to see pediatric patients of all ages, including infants, toddlers, and teens.

About Kids & Teens Dental Place

Kids & Teens Dental Place is a premier pediatric dentistry practice with locations in Pearland and Houston, TX. Call (713) 413-8282 to schedule an appointment at the Pearland office, which is located at 11041 Shadow Creek Parkway, Suite 125, Pearland, TX 77584. Call 713-662-3199 to make an appointment at the Houston office, which is located at 9540 S Main St, Ste 100, Houston, TX 77025. To learn more, visit https://www.kidsandteensdentalplace.com.

Share article on social media or email:

The Ironic Twist of Technology This innovative app sends daily doses of romance straight to your phone through sweet and flirty messages.


In a world where technology seems to be taking over every aspect of our lives, it can be easy to feel disconnected from the human experience. But what if there was an app that not only provided daily affirmations and positivity, but also brought a real human touch to the process? Enter Pink Kisses, the revolutionary new app that does just that in a way that is both empowering and ironic.

Unlike other affirmation and motivational apps, Pink Kisses doesn’t rely on AI algorithms to generate its messages. Instead, the sweet texts and compliments that users receive each day are written by the Pink Wisdom team, which is spearheaded by Alison Chace, the founder and creator of Pink Kisses. She is the brains behind the sass and her creative collaborators, Kate Robards, an award-winning playwright and comedian, and Lucie Fleming, a Stanford Graduate, and co-producer of Alison’s award-winning short documentary Under the Same Sky.

One of the best features of Pink Kisses is that users have the ability to name their “simulator sweetie” whatever they desire and switch it up as often as they like, adding to the personalization and control that users have over the app. Users can name it after a celebrity crush, a current partner, or even an imaginary dream lover, making the app their own and personalizing their experience with Pink Kisses.

This unique approach to creating an app is not only empowering but also ironic as it turns the traditional dynamic between humans and technology on its head. Instead of feeling like we’re being controlled by an AI bot, Pink Kisses gives users the power to control the simulation. By choosing their “simulator sweetie” and giving feedback on the messages they receive, users are actively shaping the experience. The Pink Wisdom team’s messages come from a place of genuine human connection and understanding, something that AI can never replicate.

“We see Pink Kisses as a way to take the power back from AI take-overs,” says Alison Chace, founder of Pink Kisses. “We are embracing the next chapter but keeping it with a human touch that AI can never duplicate.” This human touch is what sets Pink Kisses apart from other apps of its kind and makes it a truly unique and valuable resource for users.

In addition to its unique approach, Pink Kisses also offers a host of other benefits for users. Firstly, it helps users to maintain a daily routine of digital self-care. The app is designed to remind you that you deserve to be treated with kindness and love, reminding you to focus on your own happiness and well-being.

Share article on social media or email:

Weinberg Elder Law Announces Exclusive Focus on Guardianships and Conservatorships for Vulnerable Populations


News Image

My goal is to help families and friends provide for the care of individuals who lack the ability to care for themselves while ensuring that the protected parties maintain their rights and their dignity.

Weinberg Elder Law, LLC announced today that the firm is refocusing exclusively on Georgia guardianships and conservatorships. By focusing in this area of what is called fiduciary law, Weinberg will be able to allocate 100% of her resources to protect Georgia’s most vulnerable citizens.

“Since beginning my elder law practice in 2005, I have seen an increasing number of seniors and other individuals with disabilities who need the legal protections that come with guardianship and conservatorship,” said Diane Weinberg. “After much thought and consideration, Weinberg Elder Law has decided to focus its services exclusively on these types of protective proceedings and the related issues.”

In Georgia, any adult who lacks sufficient capacity to make or communicate significant responsible decisions about his or her health and safety is a candidate for a guardianship. A conservatorship is appropriate for individuals who lack sufficient capacity to make or communicate significant responsible decisions for the management of their property.

“I joke that while I began this practice in elder law, I have increasingly become a civil rights attorney protecting the rights of vulnerable populations. My goal is to help families and friends provide for the care of individuals who lack the ability to care for themselves while ensuring that the protected parties maintain their rights and their dignity.” said Weinberg. “In our practice, we strive to deliver the highest quality legal services for families experiencing the hardships that impact seniors and individuals with disabilities.”

Despite an aging population, there is no national data concerning the number of guardianships in the United States. An August 11, 2022 article from the Center for American Progress (https://www.americanprogress.org/article/rethinking-guardianship-to-protect-disabled-peoples-reproductive-rights/) estimates that 1.3 million Americans currently live under some form of guardianship. Additionally, news reports concerning celebrities like Casey Kasem and Brittney Spears highlight the possibility of abuse by family members and court-appointed fiduciaries who are supposed to protect them.

Weinberg Elder Law remains committed to finding the balance required to help families protect individuals with cognitive impairment while protecting those individuals’ rights and providing them with the best possible quality of life.

About Weinberg Elder Law

Weinberg Elder Law, LLC provides legal services designed to help Georgia’s seniors and their families navigate the complex process of aging. Founder Diane Weinberg, JD, is a member of the State Bar of Georgia, a Veterans Administration Accredited Attorney, a member of the Atlanta Bar Association, Academy of Special Needs Planners, and the National Academy of Elder Law Attorneys. She is also the State Ambassador for the Georgia Chapter of the National Academy of Elder Law Attorneys. Ms. Weinberg is the only private practice attorney in Georgia to have earned certification as an ACT (At Risk Adult Certification Training) offered through the Georgia Department of Human Services, Division of Aging Services. For more information, visit http://www.weinbergelderlaw.com

Share article on social media or email: